Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Engert

Showing results (11-20 of 173) with videos related to

Pageof 18
Sort By:
International Journal of Molecular Medicine|October 13, 2000
Recombinant immunotoxins for the treatment of Hodgkin's disease (Review)B Matthey, A Engert, S Barth
Seminars in Hematology|August 26, 1999
Treatment of advanced Hodgkin's lymphoma: standard and experimental approachesA Engert, J Wolf, V Diehl
European Journal of Haematology. Supplementum|July 13, 2005
Immunotherapy of Hodgkin's lymphomaP Borchmann, R Schnell, A Engert
Behring Institute Mitteilungen|May 1, 1984
Experimental chemotherapy of heterotransplanted Hodgkin- and non-Hodgkin-lymphoma cell lines in nude miceH H Kirchner, A Engert, V Diehl
Current Topics in Microbiology and Immunology|July 22, 1998
The emerging role of ricin A-chain immunotoxins in leukemia and lymphomaA Engert, E A Sausville, E Vitetta
Annals of Hematology|July 12, 2001
Primary lymphoma of the conjunctiva--a rare manifestation of indolent non-Hodgkin's lymphomaM Reiser, A Josting, V Diehl, et al.
Medizinische Klinik (Munich, Germany : 1983)|November 11, 1999
[Anti-angiogenesis: a new approach to tumor therapy?]D Schiefer, C Gottstein, V Diehl, et al.
Bailliere'S Clinical Haematology|September 1, 1996
Hodgkin's disease. Future treatment strategies: fact or fiction?R Schnell, S Barth, V Diehl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Current clinical trials in Hodgkin's diseaseK Reuss, A Engert, H Tesch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Development of immunotoxins for potential clinical use in Hodgkin's diseaseS Barth, R Schnell, V Diehl, et al.
Pageof 18

Showing results (11-20 of 173) with videos related to

Sort By:
Pageof 18
International Journal of Molecular Medicine|October 13, 2000
Recombinant immunotoxins for the treatment of Hodgkin's disease (Review)B Matthey, A Engert, S Barth
Seminars in Hematology|August 26, 1999
Treatment of advanced Hodgkin's lymphoma: standard and experimental approachesA Engert, J Wolf, V Diehl
European Journal of Haematology. Supplementum|July 13, 2005
Immunotherapy of Hodgkin's lymphomaP Borchmann, R Schnell, A Engert
Behring Institute Mitteilungen|May 1, 1984
Experimental chemotherapy of heterotransplanted Hodgkin- and non-Hodgkin-lymphoma cell lines in nude miceH H Kirchner, A Engert, V Diehl
Current Topics in Microbiology and Immunology|July 22, 1998
The emerging role of ricin A-chain immunotoxins in leukemia and lymphomaA Engert, E A Sausville, E Vitetta
Annals of Hematology|July 12, 2001
Primary lymphoma of the conjunctiva--a rare manifestation of indolent non-Hodgkin's lymphomaM Reiser, A Josting, V Diehl, et al.
Medizinische Klinik (Munich, Germany : 1983)|November 11, 1999
[Anti-angiogenesis: a new approach to tumor therapy?]D Schiefer, C Gottstein, V Diehl, et al.
Bailliere'S Clinical Haematology|September 1, 1996
Hodgkin's disease. Future treatment strategies: fact or fiction?R Schnell, S Barth, V Diehl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Current clinical trials in Hodgkin's diseaseK Reuss, A Engert, H Tesch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Development of immunotoxins for potential clinical use in Hodgkin's diseaseS Barth, R Schnell, V Diehl, et al.
Pageof 18